期刊文献+

唾液酸化的路易斯-X抗原和PTEN表达与肝细胞癌转移和预后的关系 被引量:1

The Expression of Sialyl Lewis-X and PTEN in Relation to the Metastasis and Prognosis in Hepatocellular Carcinoma
下载PDF
导出
摘要 目的 :探讨唾液酸化的路易斯 -X抗原 (sialylLewis -X ,SLeX)和PTEN表达与肝细胞癌 (HCC)转移和预后的关系。方法 :应用免疫组织化学方法 ,检测分析 110例HCC组织中SLexPTEN蛋白表达 ,结合随访资料分析。结果 :在HCC中 ,SLeX和PTEN阳性表达率分别为 39 1%和 33 6 %。SleX阳性表达的HCC转移率高 (P<0 0 5 )、分化程度和患者 >5年生存率低 (P <0 0 5 ) ;PTEN阳性表达的HCC转移率低 (P <0 0 5 )、分化程度和患者 >5年生存率高 (P <0 0 5 )。SLeX表达与PTEN表达呈负相关 (r=- 0 5 7,P <0 0 0 5 )。结论 :SLeX和PTEN表达与HCC转移和患者生存期密切相关 。 Objective:To investigate the correlation of sialyl Lewis-X(SLeX)and PTEN expression with potential of metastasis and prognosis in hepatocellular carcinoma(HCC).Methods:Immunohistochemical method was used to detect SLeX and PTEN expression in 110 cases of HCC.Results:The positive expression rate of SLeX and PTEN in HCC was 39.1% and 33.6% respectively.HCC with positive expression of SLeX had higher metastatic rate(P<0.05)and poorer survival rate in 5 years(P<0.05);HCC with positive PTEN expression had lower metastatic rate(P<0.05)and higher survival rate in 5 years(P<0.05).The expression of SLeX showed a reverse correlation with PTEN expression in HCC(r=-0.57,P<0.005).Conclusion:These data showed PTEN the expression of SLeX and PTEN was closely related to the potential of metastasis and survival rate in HCC.SLeX and PTEN might be the prognostic indicators in HCC.
出处 《华西医学》 CAS 2004年第3期377-378,共2页 West China Medical Journal
关键词 唾液酸化 路易斯-X抗原 PTEN 肝细胞癌 肿瘤转移 预后 Hepatocellular carcinoma sialyl Lewis-X PTEN Metastasis Prognosis
  • 相关文献

参考文献6

  • 1Yamaguchi A,Goi T,Seki K,et al.Chinical significance of combined immunohistochemical detection of CD44v6 and sialyl Lex expression for colorectal cancer patients undergoing curative resection[J].Oncology,1998;55(5)∶400-403.
  • 2Brooks SA,Leathem AJC.Expression of the CD15 antigen(Lewis X)in breast cancer[J].Histochem J,1995;27(9):689-693.
  • 3Konety BR,Bullou B,Jaffe R,et al.Expression of SSEA-1(Lewis X)on transitional cell carcinoma of the bladd[J].Urol Int,1997,58(2):69-74.
  • 4Li J,Yen C,Liaw D,et al.PTEN,a putative protein tyrosine phosphatae gene mutated in human brain,breast,and prostate cancer[J].Science,1997;275(5308):1943-1947.
  • 5Depwski PL,Rosenthal SI,Roes JS.Loss of expterssion of the PTEN gene protein product is associated with poor outcome in breast cancer[J].Mod Pathol,2001;14(7):672-676.
  • 6谷化平,尚培中,刘艳茹.唾液酸化路易斯-X抗原和CD44v6表达与胆管癌生物学行为的关系[J].中国普外基础与临床杂志,2003,10(5):442-444. 被引量:2

二级参考文献7

共引文献1

同被引文献8

  • 1Lindholm L,Johansson C ,Jansson EL,et al. An inmluno-radiometricassay (IRMA) for the CA50 antigen. In : Hoimgren J, ed. Tumour marker antigen [M].Lund, Sweden. Studentlitteratur, 1985. 123-133.
  • 2Steek PA, Pelshouse MA, Jasser SA, et al. Identification of a candidate tumor suppressor gene, MMACI,at chromosome 10q23.3 that is mutated in multiple advanced cancem[J]. Nat Genet, 1997,15 :356-362.
  • 3Depwski PL, Rosenthal SI, Roes JS. Loss of expterssion of the PTEN gene protein product is associated with poor outcome in breast cancer[J]. Mod Pathol,2001,14 :672-676.
  • 4Mutter GL, Incc TA, Baak JP, et al. Molecular identification of latent precancers in histologically normal endometrium [J]. Cancer Res,2001,61:4311-4314.
  • 5Huang J, Kontos CD. PTEN modulates vascular endothelial growth factor mediated signaling and angiogenis effects[J]. J Biol Chem,2002,277 : 10760 -10766.
  • 6徐笑红,束新华,卢加荪,沈波,郭剑民.血清CA242、CA19-9在胰腺癌诊断和治疗中的应用评估[J].标记免疫分析与临床,2001,8(3):185-187. 被引量:6
  • 7刘毓键,朱理玮,王鹏志.胃癌细胞CA242表达与肿瘤播散潜力关系研究[J].天津医药,2003,31(6):352-354. 被引量:6
  • 8刘嘉,陈年秀,鞠冬阳.CA199及CA242在大肠癌患者血清和组织中表达的意义[J].贵阳医学院学报,2003,28(6):484-488. 被引量:7

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部